Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

Avai Bio (AVAI) Cash from Operations (2018 - 2024)

Avai Bio's Cash from Operations history spans 6 years, with the latest figure at 136522.0 for Q1 2024.

  • For Q1 2024, Cash from Operations fell 85.76% year-over-year to 136522.0; the TTM value through Mar 2024 reached 1322318.0, down 2328.19%, while the annual FY2025 figure was 1160610.0, 12.23% up from the prior year.
  • Cash from Operations for Q1 2024 was 136522.0 at Avai Bio, up from 705669.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 109582.0 in Q1 2020 and bottomed at 705669.0 in Q4 2023.
  • The 4-year median for Cash from Operations is 66609.5 (2023), against an average of 129119.4.
  • The largest annual shift saw Cash from Operations surged 4929.53% in 2020 before it plummeted 2265.56% in 2023.
  • A 4-year view of Cash from Operations shows it stood at 24001.0 in 2020, then skyrocketed by 235.77% to 32586.0 in 2022, then tumbled by 2265.56% to 705669.0 in 2023, then skyrocketed by 80.65% to 136522.0 in 2024.
  • Per Business Quant, the three most recent readings for AVAI's Cash from Operations are 136522.0 (Q1 2024), 705669.0 (Q4 2023), and 420401.0 (Q3 2023).